CS1:PA:PA-Amundi IBEX 35 UCITS ETF Acc (EUR)

ETF | Others |

Last Closing

USD 321.9

Change

+3.50 (+1.10)%

Market Cap

USD 0.10B

Volume

711.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.10 (+0.23%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.20 (+0.23%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.68 (+0.18%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

+0.16 (+0.48%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+2.11 (+0.82%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-0.20 (-0.05%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.51 (+0.45%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

+0.12 (+0.23%)

USD 7.67B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.89B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+0.99 (+1.20%)

USD 5.54B

ETFs Containing CS1:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.63% 94% A 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.63% 94% A 82% B
Trailing 12 Months  
Capital Gain 29.23% 95% A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.23% 95% A 90% A-
Trailing 5 Years  
Capital Gain 144.12% 84% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 144.12% 81% B- 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 15.99% 81% B- 79% B-
Dividend Return 15.99% 80% B- 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.99% 53% F 75% C
Risk Adjusted Return 123.16% 93% A 96% N/A
Market Capitalization 0.10B 28% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.